Cardinal Health (NYSE:CAH) is staring down its top two competitors for a U.S. Department of Veterans Affairs (VA) drug distribution contract that could be worth up to $32 billion.In January, Dublin, Ohio-based Cardinal should know whether it or AmerisourceBergen (NYSE:ABC) or McKesson (NYSE:MCK) has won the giant VA contract, Bloomberg News reported.Since 2004, McKesson has [...]

For pharmaceuticals distributor Cardinal Health (NYSE:CAH), China represents a world of opportunity.Now — after the $470 million acquisition last year of Chinese drug distributor Yong Yu and the recent opening of a new logistics center in Shanghai — Cardinal just needs to figure out which of those opportunities to pursue.In addition to growing its drug [...]

Cardinal Health (NYSE:CAH) has teamed up with an East Coast insurer to launch a best clinical practices care program for patients suffering from rheumatoid arthritis.Cardinal’s partnership with CareFirst BlueCross BlueShield involves adding rheumatoid arthritis (RA) to its P4 clinical pathways program, an initiative that helps insurers and physicians to work together to develop evidence-based [...]

Pharmaceuticals distributor Cardinal Health (NYSE:CAH) reported increased, adjusted first-quarter earnings, but investors showed only modest enthusiasm as the company’s full-year outlook remained the same.Cardinal reported adjusted earnings from continuing operations of $256 million, or 73 cents per diluted share, compared with $231 million or 66 cents per diluted share a year earlier, according to a [...]

Cardinal Health (NYSE:CAH) has acquired for $165 million a Canadian medical products supplier that focuses on selling to nursing homes.The purchase of Futuremed Healthcare Products strengthens Dublin, Ohio-based Cardinal’s presence in Canada and offers Cardinal new customers for its existing medical products.Futuremed specializes in selling consumable nursing home supplies and furniture, and equipment to long-term [...]

Cardinal Health (NYSE:CAH) has secured exclusive North American marketing rights for a recently cleared staph-infection blood test from diagnostics company MicroPhage.In exchange, Dublin, Ohio-based Cardinal has provided MicroPhage with an unspecified amount of operational funding for development and commercialization of new products, according to a statement from MicroPhage.Reached by phone, MicroPhage officials declined to specify [...]

While just a small part of Cardinal Health‘s (NYSE:CAH) $100 billion-plus revenue, the nuclear medicine business is an important driver of higher margins for the drug distribution company.In particular, positron emission tomography (PET) radiopharmaceuticals — which are used to aid in imaging scans for cancer, heart disease and brain disorders — are poised to be [...]

Cardinal Health (NYSE:CAH) sees a big growth opportunity in the specialty drugs distribution market, but catching up with its top two rivals could be a tough slog.Specialty drugs are typically complex, injectable biologics that are used to treat somewhat small groups of patients for specific conditions like multiple sclerosis, cystic fibrosis and certain types of [...]

Drug distributor Cardinal Health (NYSE: CAH) reported a 19 percent fourth-quarter increase in sales of generic drugs, an area that continues to be a strength for the company.Generics — as well as acquisitions that have allowed the company to sell more generics — contributed to a 9 percent increase in fourth-quarter revenue to $26.8 billion, [...]

Pharmaceuticals distributor Cardinal Health (NYSE: CAH) has opened a molecular imaging center with the goal of developing new radioactive imaging agents that will help doctors treat a wide range of diseases like cancer, heart disease and neurological disorders.Cardinal scientists, engineers and manufacturing experts will work with clients in the pharmaceutical and academic research industries at [...]